L. Villa

发表

Mutants of pertussis toxin suitable for vaccine development.

L. Nencioni, M. Pizza, R. Manetti, 1989, Science.

Binding and internalization of the 163-171 fragment of human IL-1 beta.

G. Scapigliati, D. Boraschi, A. Tagliabue, 1992, Cytokine.

Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo

T. Witham, I. Pollack, P. Robbins, 2003, Journal of Neuro-Oncology.

Expression of a Soluble Transforming Growth Factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo

T. Witham, I. Pollack, P. Robbins, 2004, Journal of Neuro-Oncology.

Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA

L. Nencioni, D. Boraschi, L. Villa, 1983, Nature.

IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells.

L. Nencioni, R. Rappuoli, D. Boraschi, 1984, Journal of immunology.

Flt‐3 ligand (FL) drives differentiation of rat bone marrow‐derived dendritic cells expressing OX62 and/or CD161 (NKR‐P1)

W. Chambers, C. Brissette-Storkus, D. Potter, 2002, Journal of leukocyte biology.

Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.

Simon C Watkins, D. Kondziolka, T. Witham, 2002, Cancer research.

Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines

P. Matricardi, L. Nencioni, R. Nisini, 1988, Infection and immunity.

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.

D. Boraschi, A. Tagliabue, S. Censini, 1986, Journal of immunology.

Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies.

L. Nencioni, G. Peri, D. Boraschi, 1985, Journal of immunology.

IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1986, Journal of immunology.

In vitro generated mast cells express natural cytotoxicity against tumour cells.

G. Scapigliati, D. Boraschi, A. Tagliabue, 1985, Immunology.

Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.

L. Nencioni, D. Boraschi, A. Tagliabue, 1983, Journal of immunology.

Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.

P. Bossù, L. Nencioni, D. Boraschi, 1990, European journal of immunology.

IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.

L. Nencioni, P. Sestini, D. Boraschi, 1988, The American review of respiratory disease.

Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.

L. Nencioni, P. Sestini, D. Boraschi, 1987, Advances in experimental medicine and biology.

NATURAL ANTIBACTERIAL ACTIVITY AGAINST CORD BLOOD SaZrnoneZZa typhi IN HUMAN

S. Nuti, D. Boraschi, A. Tagliabue, 1989 .

Recombinant Protein Antigens with ‘Built-in’ Adjuvanticity

L. Castagnoli, G. Cesareni, R. Rappuoli, 1993 .

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta

G Doria, P. Bossù, L. Nencioni, 1988, The Journal of experimental medicine.

In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Journal of immunology.

Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

I. Pollack, M. Lotze, W. Chambers, 2000, Cancer research.

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

H. Okada, M. Lotze, I. Pollack, 2001, Gene Therapy.

Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.

C. Martínez-A, I. Mérida, A. De La Hera, 2001, Clinical immunology.

Increasing the immunogenicity of protein antigens through the genetic insertion of VQGEESNDK sequence of human IL-1 beta into their sequence.

L. Castagnoli, G. Cesareni, S. Gonfloni, 1993, Journal of immunology.

Biological role of the IL-1 receptor type II (IL-1RII) as defined by a monoclonal antibody

P. Bossù, G. Scapigliati, S. Nuti, 1991 .

A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.

L. Nencioni, G. Scapigliati, D. Boraschi, 1989, Journal of immunology.

Essential for Protective Immunity T Cells by Interleukin-4-transfected 9 L Gliosarcoma Is + Cytokine Gene Therapy of Gliomas : Induction of Reactive CD 4 Updated Version

I. Pollack, M. Lotze, W. Chambers, 2000 .

Cellular immunity against Salmonella typhi after live oral vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Advances in experimental medicine and biology.

IgA-Armed T Lymphocytes as Anti-S. Typhi Effectors in Humans

L. Nencioni, D. Boraschi, A. Tagliabue, 1988 .

Antibacterial activity of lymphocytes armed with IgA.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Advances in experimental medicine and biology.

Cellular immunity against Salmonella typhi after live oral vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Clinical and Experimental Immunology.

Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugars

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Infection and immunity.

Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice.

L. Nencioni, D. Boraschi, A. Tagliabue, 1984, Clinical and experimental immunology.

Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.

P. Ghezzi, L. Nencioni, M. Salmona, 1983, Immunology.

Radiolabeling of the biologically active peptide 163-171 of human interleukin-1 beta.

D. Boraschi, G. Antoni, L. Villa, 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Interleukin 1 and its synthetic peptides as adjuvants for poorly immunogenic vaccines.

P. Bossù, L. Nencioni, A. Tagliabue, 1989, Advances in experimental medicine and biology.

Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Lymphokine research.

Synthesis and Biological Activity of the Immunomodulatory Site of Interleukin 1

L. Nencioni, D. Boraschi, A. Tagliabue, 1987 .

Isradipine, a calcium-channel antagonist, has immunosuppressor activity on T lymphocytes from peripheral blood and synovial fluid from patients with autoimmune arthritis.

H. Rico, A. Prieto, A. Zea, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.